Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TAL1 anticorps

TAL1 Reactivité: Rat IHC, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7075819
  • Antigène Voir toutes TAL1 Anticorps
    TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
    Reactivité
    • 84
    • 38
    • 25
    • 6
    • 6
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    Rat
    Hôte
    • 83
    • 10
    Lapin
    Clonalité
    • 84
    • 9
    Polyclonal
    Conjugué
    • 52
    • 7
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TAL1 est non-conjugé
    Application
    • 68
    • 45
    • 13
    • 9
    • 8
    • 7
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), Immunofluorescence (IF)
     Réactivité croisée
    Rat
    Purification
    Affinity purification
    Immunogène
    Recombinant protein corresponding to Mouse Tal1
    Top Product
    Discover our top product TAL1 Anticorps primaire
  • Indications d'application
    IHC/IF (R) 1:800-1:1500/1:400-1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS, pH 7.4, 0.02 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
  • Antigène
    TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
    Autre désignation
    Tal1 (TAL1 Produits)
    Synonymes
    anticorps SCL/tal-1, anticorps Scl, anticorps bHLHa17, anticorps tal-1, anticorps SCL, anticorps TCL5, anticorps scl, anticorps tcl5, anticorps SCL-alpha, anticorps SCL-beta, anticorps scl/tal1, anticorps zgc:85605, anticorps T cell acute lymphocytic leukemia 1, anticorps TAL bHLH transcription factor 1, erythroid differentiation factor, anticorps T-cell acute lymphocytic leukemia 1 S homeolog, anticorps T-cell acute lymphocytic leukemia 1, anticorps Tal1, anticorps TAL1, anticorps tal1.S, anticorps tal1
    Sujet
    Activation of TAL1 characterizes up to 60 % of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. This transcription factor binds as a heterodimer with E2A and HEB/HTF4 to a nucleotide sequence motif termed the E-box. In addition, leukemogenesis is accelerated dramatically by transgenic co-expression of TAL1 and the catalytic subunit of casein kinase alpha, a serine/ threonine protein kinase known to modulate the activity of other bHLH transcription factors.
    ID gène
    21349
    NCBI Accession
    NP_001274317
    UniProt
    P22091
    Pathways
    Stem Cell Maintenance
Vous êtes ici:
Support technique